Filing Details

Accession Number:
0001179110-11-009418
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-06-08 14:42:45
Reporting Period:
2011-06-06
Filing Date:
2011-06-08
Accepted Time:
2011-06-08 14:42:45
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
882095 Gilead Sciences Inc GILD Biological Products, (No Disgnostic Substances) (2836) 943047598
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1314870 Kristen Metza Gilead Sciences, Inc.
333 Lakeside Drive
Foster City CA 94404
Svp, Human Resources No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-06-06 5,500 $28.26 21,302 No 4 M Direct
Common Stock Disposition 2011-06-06 5,500 $40.97 15,802 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (Right to Buy) Disposition 2011-06-11 5,500 $0.00 5,500 $28.26
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
9,500 2016-05-09 No 4 M Direct
Footnotes
  1. The stock options have a five year vesting schedule. 20% of the options vested on May 9, 2007, the first anniversary of the grant. The balance vested 5% quarterly thereafter until fully vested on May 9, 2011. The options expire on May 9, 2016.
  2. Sale prices reported for the transaction reported here range from $40.83 to $41.07. Full information regarding the number of shares purchased or sold at each price will be provided to the SEC, the issuer or its shareowners upon request.